sodium clodronate

sodium clodronate

A drug that prevents bone loss by interfering with the cells (osteoclasts) that break down bone. Brand names are Bonefos and Loron.
Mentioned in ?
References in periodicals archive ?
The research study, jointly led by Prof Malcolm Mason, at Cardiff University, and Prof David Dearnaley, of the Institute of Cancer Research, examined the long-term effect of sodium clodronate on men with prostate cancer.
The research study, jointly led by Prof Malcolm Mason at Cardiff University and Prof David Dearnaley of the Institute of Cancer Research, examined the long-term effect of sodium clodronate on men with advanced and localised prostate cancer.
The study, which was funded by the Medical Research Council and is published today in The Lancet Oncology, found that after five years the overall survival rate for men with advanced prostate cancer was 30% for those who had been taking sodium clodronate and 21% among those who weren't.